Stock screenerAll disclosures →
EDGAR →
VERU
Conviction 53HealthcareScan · Thu, Jun 25, 2026VERU$2.94-1.01%
ResistanceSupportVol 14Vol MA14 1.54M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest -76.92%· 3 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.94
Change-1.01%
Gap-0.51%
Rel volume0.06×
Avg volume5.74M
Avg $ vol23.16M
SMA 202.94
SMA 502.54
SMA 2002.72
Price vs 50+15.69%
Price vs 200+7.92%
MA stackmixed
50/200 cross—
Supertrendup · 2.83
RSI (14)53
MACD hist-0.03
MACD crossbear · 4d
Stoch %K / %D8 / 14
ADX (14)52
+DI / −DI41 / 10
RSI divergence—
MACD divergence—
ATR %+11.74%
ADR %14.22%
52w high4.43
52w low0.3655
From 52w high-33.63%
Above 52w low+704.38%
New 52w highNo
SqueezeOff
Bollinger width60.50%
%B0.50
Donchian pos15.90%
Donchian high7.33
Donchian low2.11
AVWAP (52w high)4.33
vs AVWAP high-32.15%
AVWAP (52w low)3.88
vs AVWAP low-24.25%
OBV trendUp
Chaikin MF (20)-0.25
Today vs 20d0.06×
Avg vol (14d)1.54M
Avg vol (20d)5.74M
Avg $ vol (20d)23.16M
Market cap47.19M
RS 3m (vs SPY)+17.44%
RS 6m (vs SPY)+20.28%
RS line new highNo
Trend template4/8
Technical rank78.8
1 week-1.67%
1 month+27.27%
3 months+28.38%
6 months+28.38%
1 year+340.19%
YTD+29.52%
P/E-2.08
P/B1.36
P/S2.79
P/FCF-1.57
EPS-1.10
Div yield0.01%
ROE-65.33%
ROA-52.75%
Debt/Eq0.05
Current6.19
EV/EBITDA-0.87
Gross margin34.67%
Net margin-134.58%
Rev growth3.62%
EPS growth39.88%
Price target25.00
Target upside750.34%
Analyst ratingBuy
Institutional27.82%
Ent. value21.29M
Revenue0
Net income-2.74M
Gross profit1.34M
Free cash flow-30.04M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out16.05M
Employees20
ListedFri, Jun 1, 1990
Free float13.65M
Float %85.1%
Short interest564.55K
Days to cover8.4d
Short volume48.1%
Squeeze score39 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.37
Last surprise+64.9% beat
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank78.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.34
Support2.08
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VERU
No recent disclosed trades by Congress in VERU. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VERU · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
FISCH HARRY Chief Corporate Officer · Common Stock Option · 2026-05-04 | Grant | 160K | $0 | 2026-05-04 | 2026-05-06 |
STEINER MITCHELL SHUSTER President and CEO · Common Stock Option · 2026-05-04 | Grant | 604K | $0 | 2026-05-04 | 2026-05-06 |
Hyun Grace Director · Common Stock Option · 2026-05-04 | Grant | 97K | $0 | 2026-05-04 | 2026-05-06 |
Lu Lucy Director · Common Stock Option · 2026-05-04 | Grant | 104K | $0 | 2026-05-04 | 2026-05-06 |
Rankowitz Michael L Director · Common Stock Option · 2026-05-04 | Grant | 100K | $0 | 2026-05-04 | 2026-05-06 |
Greco Michele Chief Admin Officer and CFO · Common Stock Option · 2026-05-04 | Grant | 164K | $0 | 2026-05-04 | 2026-05-06 |
Katzovitz Loren Mark Director · Common Stock Option · 2026-05-04 | Grant | 102K | $0 | 2026-05-04 | 2026-05-06 |
BARNETTE K GARY Chief Scientific Officer · Common Stock Option · 2026-05-04 | Grant | 160K | $0 | 2026-05-04 | 2026-05-06 |
SEC filings
EDGAR filings in VERU · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.